Trial Profile
German Tysabri-Data-Register
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2020
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 15 Sep 2016 New trial record